Gelesis Obtains $12,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    222 Berkeley St. Boston, MA 02116 USA
  • Company Description
    Gelesis is a Boston-based company developing a breakthrough treatment for obesity and other related co-morbidities.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    We’re very excited both by Gelesis100’s development to date and by its path forward to commercialization, as supported by this funding.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy